AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 152 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $8,504,000 | +4048.3% | 562,108 | +1954.9% | 0.00% | – |
Q2 2022 | $205,000 | -13.1% | 27,354 | +5.6% | 0.00% | – |
Q1 2022 | $236,000 | +61.6% | 25,901 | +24.5% | 0.00% | – |
Q4 2021 | $146,000 | -57.6% | 20,812 | -30.9% | 0.00% | – |
Q3 2021 | $344,000 | -26.8% | 30,105 | +2.4% | 0.00% | – |
Q2 2021 | $470,000 | +8.3% | 29,400 | +21.1% | 0.00% | – |
Q1 2021 | $434,000 | +93.8% | 24,274 | +46.2% | 0.00% | – |
Q4 2020 | $224,000 | +43.6% | 16,604 | +21.4% | 0.00% | – |
Q3 2020 | $156,000 | -14.8% | 13,676 | +10.0% | 0.00% | – |
Q2 2020 | $183,000 | -2.7% | 12,428 | -10.7% | 0.00% | – |
Q1 2020 | $188,000 | -90.3% | 13,920 | -82.6% | 0.00% | – |
Q4 2019 | $1,936,000 | +627.8% | 80,124 | +479.0% | 0.00% | – |
Q3 2019 | $266,000 | -21.1% | 13,839 | +19.4% | 0.00% | – |
Q2 2019 | $337,000 | -17.8% | 11,595 | +34.2% | 0.00% | – |
Q1 2019 | $410,000 | +25.0% | 8,642 | -4.9% | 0.00% | – |
Q4 2018 | $328,000 | -35.3% | 9,086 | +10.3% | 0.00% | – |
Q3 2018 | $507,000 | -8.5% | 8,239 | +0.4% | 0.00% | – |
Q2 2018 | $554,000 | +33.8% | 8,206 | +7.7% | 0.00% | – |
Q1 2018 | $414,000 | -64.6% | 7,619 | -61.1% | 0.00% | – |
Q4 2017 | $1,169,000 | -19.7% | 19,570 | -49.1% | 0.00% | – |
Q4 2016 | $1,455,000 | +29000.0% | 38,452 | +13439.4% | 0.00% | – |
Q2 2016 | $5,000 | -28.6% | 284 | -52.3% | 0.00% | – |
Q1 2016 | $7,000 | 0.0% | 596 | +109.9% | 0.00% | – |
Q4 2015 | $7,000 | -99.9% | 284 | -99.9% | 0.00% | -100.0% |
Q3 2014 | $5,084,000 | – | 245,733 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|